المؤلفون: Zou Qingwei, Ling Han, William K. Decker, Chong Huo, Nikita Kotlov, Michael A. Davies, Cassian Yee, David H. Hawke, Kyle R. Jackson, Gregory Lizée, Caixia Chen, Shuo Zhou, Arjun S. Katailiha, Zhenglu Wang, Deng Ligang, Chantale Bernatchez, Amjad H. Talukder, Wang Yaling, Yulun Chiu, Minying Zhang, Natalia Miheecheva, Felix Frenkel, Matthew Stair, Yan Zhang, Weihong Feng, Jason Roszik, Xueming Du, Patrick Hwu, Aleksander Bagaev, Marie Andrée Forget, Sherille D. Bradley, Roland L. Bassett, Viktor Svekolkin, Ataullakhanov Ravshan I, Fenge Li, Heather M. Sonnemann

المصدر: Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, T cell, medicine.medical_treatment, EGFR, tumor regression, Immunology, Context (language use), 03 medical and health sciences, T790M, 0302 clinical medicine, Immune system, Internal medicine, medicine, Immunology and Allergy, Lung cancer, RC254-282, non-small cell lung cancer, EGFR inhibitors, neoantigen vaccine, Pharmacology, Clinical/Translational Cancer Immunotherapy, Chemotherapy, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, EGFR inhibitor, 030104 developmental biology, medicine.anatomical_structure, Tolerability, 030220 oncology & carcinogenesis, Molecular Medicine, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::116fdd0c7589d13331b363ecec16623fTest
http://europepmc.org/articles/PMC8268925Test

المؤلفون: Jason K. Kim, Sarah Kolitz, Rebecca Kusko, Jenny Z. Zhang, Howard L. Kaufman, Benjamin Zeskind, Rajaraman Krishnan, Yoonjeong Cha, Sailaja Battula

المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)

مصطلحات موضوعية: 0301 basic medicine, Drug, Virus quantification, Quantitative structure–activity relationship, business.industry, media_common.quotation_subject, Pharmacology, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Approved drug, lcsh:RC254-282, Virus, 03 medical and health sciences, Drug repositioning, Titer, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Medicine, business, EGFR inhibitors, media_common

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::485817786f9c25a9e34e00b107767402Test
https://doaj.org/article/08742e93fdd9484eab94fdfc5ef8d65aTest

المؤلفون: Daniella Jenni, J. Mangana, Jil Dreier, Maria B. Karpova, Jürg Hafner, Beda Mühleisen, Reinhard Dummer

المساهمون: University of Zurich, Dummer, R

المصدر: ESMO Open

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, 610 Medicine & health, Lapatinib, Organ transplantation, EGFR-inhibitors, primary and secondary preve, Internal medicine, Advanced cutaneous squamous cell carcinoma, medicine, 1306 Cancer Research, lapatinib, Adverse effect, EGFR inhibitors, business.industry, Actinic keratosis, 10177 Dermatology Clinic, medicine.disease, Surgery, Clinical trial, Tolerability, Pancreatitis, 2730 Oncology, Original Article, business, options beyond chemotherapy, medicine.drug

وصف الملف: 643_Jenni D. et al._Lapatinib_ESMO Open 2016.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7904669a1009284d06d5d9d100ac2a8Test
http://europepmc.org/articles/PMC5070204Test